Role of presymptomatic transmission of COVID-19: evidence from Beijing, China.


Journal

Journal of epidemiology and community health
ISSN: 1470-2738
Titre abrégé: J Epidemiol Community Health
Pays: England
ID NLM: 7909766

Informations de publication

Date de publication:
01 2021
Historique:
received: 23 05 2020
revised: 21 07 2020
accepted: 28 07 2020
pubmed: 29 8 2020
medline: 29 12 2020
entrez: 29 8 2020
Statut: ppublish

Résumé

The presymptomatic transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been documented in limited clusters, and it is predicted through modelling. However, there is a lack of evidence from observations with a large sample size. We used data from meticulous contact tracing of people exposed to cases of SARS-CoV-2 to estimate the proportion of cases that result from the presymptomatic transmission of the virus in Beijing during January 2020 and February 2020. The results showed that presymptomatic transmission occurred in at least 15% of 100 secondary COVID-19 cases. The earliest presymptomatic contact event occurred 5 days prior to the index case's onset of symptoms, and this occurred in two clusters. The finding suggested that the contact tracing period should be earlier and highlighted the importance of preventing transmission opportunities well before the onset of symptoms.

Sections du résumé

BACKGROUND
The presymptomatic transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been documented in limited clusters, and it is predicted through modelling. However, there is a lack of evidence from observations with a large sample size.
METHODS
We used data from meticulous contact tracing of people exposed to cases of SARS-CoV-2 to estimate the proportion of cases that result from the presymptomatic transmission of the virus in Beijing during January 2020 and February 2020.
RESULTS
The results showed that presymptomatic transmission occurred in at least 15% of 100 secondary COVID-19 cases. The earliest presymptomatic contact event occurred 5 days prior to the index case's onset of symptoms, and this occurred in two clusters.
CONCLUSIONS
The finding suggested that the contact tracing period should be earlier and highlighted the importance of preventing transmission opportunities well before the onset of symptoms.

Identifiants

pubmed: 32855261
pii: jech-2020-214635
doi: 10.1136/jech-2020-214635
pmc: PMC7788477
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

84-87

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

JAMA. 2020 Apr 14;323(14):1406-1407
pubmed: 32083643
Emerg Infect Dis. 2020 Jun;26(6):1341-1343
pubmed: 32191173
Emerg Infect Dis. 2020 May;26(5):1052-1054
pubmed: 32091386
MMWR Morb Mortal Wkly Rep. 2020 Apr 03;69(13):377-381
pubmed: 32240128
Clin Infect Dis. 2020 Jul 28;71(15):861-862
pubmed: 32201889
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):411-415
pubmed: 32271722
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168

Auteurs

Yi Zhang (Y)

Beijing Center for Disease Prevention and Control & Beijing Research Center for Preventive Medicine, Beijing, China.

David Muscatello (D)

University of New South Wales, Sydney, Australia.

Yi Tian (Y)

Beijing Center for Disease Prevention and Control & Beijing Research Center for Preventive Medicine, Beijing, China.

Yanwei Chen (Y)

Beijing Center for Disease Prevention and Control & Beijing Research Center for Preventive Medicine, Beijing, China.

Shuang Li (S)

Beijing Center for Disease Prevention and Control & Beijing Research Center for Preventive Medicine, Beijing, China.

Wei Duan (W)

Beijing Center for Disease Prevention and Control & Beijing Research Center for Preventive Medicine, Beijing, China.

Chunna Ma (C)

Beijing Center for Disease Prevention and Control & Beijing Research Center for Preventive Medicine, Beijing, China.

Ying Sun (Y)

Beijing Center for Disease Prevention and Control & Beijing Research Center for Preventive Medicine, Beijing, China.

Shuangsheng Wu (S)

Beijing Center for Disease Prevention and Control & Beijing Research Center for Preventive Medicine, Beijing, China.

Lin Ge (L)

University of Nevada Las Vegas, Las Vegas, Nevada, USA.

Peng Yang (P)

Beijing Center for Disease Prevention and Control & Beijing Research Center for Preventive Medicine, Beijing, China.

Lei Jia (L)

Beijing Center for Disease Prevention and Control & Beijing Research Center for Preventive Medicine, Beijing, China.

Quanyi Wang (Q)

Beijing Center for Disease Prevention and Control & Beijing Research Center for Preventive Medicine, Beijing, China bjcdcxm@126.com.

Chandini Raina MacIntyre (CR)

University of New South Wales, Sydney, Australia.
Arizona State University, Tempe, Arizona, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH